Follicular Lymphoma
📧 Sign up to get email alerts when something new happens for Follicular Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas [Phase 1]
Phase 1 feasibility trial evaluating the combination of tazemetostat with CAR T-cell therapy in B-cell lymphomas, including follicular lymph…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL [Phase 2]
This is an update on a Phase 2 clinical trial evaluating tafasitamab in combination with lenalidomide and rituximab in treatment-naive folli…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL [Phase 2]
Phase 2 clinical trial evaluating obinutuzumab plus ICE chemotherapy for refractory or recurrent CD20-positive mature non-Hodgkin lymphoma i…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas [Phase 1]
Phase 1 clinical trial evaluating autologous CD22-directed CAR-T cells in patients with recurrent or refractory B-cell lymphomas, including …
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL). [Phase 1, Phase 2]
This Clinical Trial Update describes a fourth-generation CD19/CD22 dual-targeting CAR T-cell therapy being evaluated in Phase 1/2 for highly…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: 64Cu-LLP2A for Imaging Hematologic Malignancies [EARLY_Phase 1]
Phase 1 imaging trial evaluating 64Cu-LLP2A in hematologic malignancies is currently recruiting, targeting multiple myeloma and various lymp…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies [Phase 1, Phase 2]
This document outlines a Phase I/II clinical trial of ALETA-001 for various B-cell lymphomas, with recruitment ongoing and sponsored by Canc…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma [Phase 3]
This clinical trial update reports a Phase 3 study of subcutaneous epcoritamab with intravenous rituximab and oral lenalidomide (R2) in adul…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Allo HSCT Using RIC and PTCy for Hematological Diseases [Phase 2]
Phase 2 clinical trial evaluating allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and post-transplan…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance
This clinical trial update describes a prospective biological study to evaluate how long immune responses from COVID-19 vaccines (and other …
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Combating Cancer-Related Fatigue: A Personalized Supportive Care Program [NA]
This clinical trial update reports a UNC Lineberger Comprehensive Cancer Center study recruiting participants for a personalized supportive …
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders [Phase 2]
Phase 2 clinical trial evaluating myeloablative allogeneic hematopoietic stem cell transplantation from related or unrelated donors for a br…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: A Multicenter, Single-Arm, Open-Label, Phase II Trial of Mosunetuzumab in Combination With Tislelizumab for r/r FL [Phase 2]
Phase II trial evaluating mosunetuzumab in combination with tislelizumab for relapsed/refractory follicular lymphoma. The study is not yet r…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: A Multi-center Clinical Study of Zanubrutinib in Combination With First-line Chemoimmunotherapy in Patients With Grade 3A High-risk Follicular Lymphoma
This clinical trial update reports an ongoing multi-center study evaluating zanubrutinib in combination with first-line chemoimmunotherapy f…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies
A clinical trial is investigating the effectiveness and safety of the CAR-T therapy tisagenlecleucel in Brazilian patients with B-lymphocyte…
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Obinutuzumab With CHOP Versus Obinutuzumab With Bendamustine in the Treatment of Newly Diagnosed Follicular Lymphoma Grade 3A [Phase 2]
This phase 2 trial compares Obinutuzumab with CHOP versus Obinutuzumab with Bendamustine in newly diagnosed Follicular lymphoma Grade 3A. Th…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Zanubrutinib Combined With G-CVP in Previously Untreated FL [Phase 2]
Phase 2 clinical trial update on zanubrutinib combined with G-CVP for previously untreated follicular lymphoma; recruitment is ongoing in Ch…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma [Phase 2]
A Phase 2 clinical trial is evaluating the combination of Brentuximab Vedotin and Bendamustine for relapsed or refractory follicular lymphom…
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: Zanubrutinib Plus GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Follicular Lymphoma [Phase 2]
This clinical trial update outlines a Phase 2 study of zanubrutinib plus GCVP (obinutuzumab, cyclophosphamide, vindesine, prednisolone) in p…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma [Phase 2]
This is a multi-center Phase 2 study evaluating oral Abexinostat as monotherapy for relapsed or refractory follicular lymphoma. The trial is…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma [Phase 2]
A Phase 2 trial evaluating Abexinostat in relapsed or refractory Follicular lymphoma is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies [Phase 1]
Phase 1 study evaluating autologous CD19 CAR-T cell therapy SYNCAR-001 with orthogonal IL-2 STK-009 in CD19-positive hematologic malignancie…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy [Phase 2]
Phase 2 frontline trial evaluating atezolizumab plus obinutuzumab with or without radiotherapy for follicular lymphoma; current status is ac…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: CD70-targeted immunoPET Imaging of Malignant Cancers [NA]
A clinical trial evaluating CD70-targeted immunoPET imaging in multiple cancers is currently recruiting, including renal cell carcinoma, dif…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies [Phase 1]
Phase 1 clinical trial update for BP1002 in advanced lymphoid malignancies across several B-cell and T-cell lymphomas; trial status is activ…